Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jenny B. Avanzini"'
Autor:
Jeff Alexander, Jason Mendy, Lo Vang, Jenny B Avanzini, Fermin Garduno, Darly J Manayani, Glenn Ishioka, Peggy Farness, Li-Hua Ping, Ronald Swanstrom, Robert Parks, Hua-Xin Liao, Barton F Haynes, David C Montefiori, Celia LaBranche, Jonathan Smith, Marc Gurwith, Tim Mayall
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e82380 (2013)
There is a well-acknowledged need for an effective AIDS vaccine that protects against HIV-1 infection or limits in vivo viral replication. The objective of these studies is to develop a replication-competent, vaccine vector based on the adenovirus se
Externí odkaz:
https://doaj.org/article/688f74a69bab4601af81fd692d862712
Autor:
Jeff Alexander, Simone Ward, Jason Mendy, Darly J Manayani, Peggy Farness, Jenny B Avanzini, Ben Guenther, Fermin Garduno, Lily Jow, Victoria Snarsky, Glenn Ishioka, Xin Dong, Lo Vang, Mark J Newman, Tim Mayall
Publikováno v:
PLoS ONE, Vol 7, Iss 2, p e31177 (2012)
Influenza virus remains a significant health and social concern in part because of newly emerging strains, such as avian H5N1 virus. We have developed a prototype H5N1 vaccine using a recombinant, replication-competent Adenovirus serotype 4 (Ad4) vec
Externí odkaz:
https://doaj.org/article/942bade51b5e4d14aa02fb115e1fab4b
Autor:
Marc Gurwith, Tim Mayall, Jenny B. Avanzini, David C. Montefiori, Jason Mendy, Barton F. Haynes, Darly J. Manayani, L Vang, Hua-Xin Liao, Peggy Farness, B Guenther, Jeff Alexander, Celia C. LaBranche
Publikováno v:
Retrovirology, Vol 9, Iss Suppl 2, p P35 (2012)
Retrovirology
Retrovirology
Background Our hypothesis is that the replicating Ad4 vector approach, may be the best strategy for an effective HIV-1 vaccine due to advantages of demonstrated clinical safety and immunogenicity of both the Ad4 backbone and an Ad4 H5N1 vector influe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d023e69e97932521ab401c375367b85
https://doaj.org/article/832de3f54cc145fcbbc89e4b7a46ef71
https://doaj.org/article/832de3f54cc145fcbbc89e4b7a46ef71
Autor:
Fermin Garduno, Jenny B. Avanzini, Simone Visosky Ward, Lily Jow, Ben Guenther, Darly J. Manayani, Jeff Alexander, Xin Dong, Victoria Snarsky, Glenn Ishioka, Mark J. Newman, Jason Mendy, Tim Mayall, Peggy Farness, Lo Vang
Publikováno v:
PLoS ONE, Vol 7, Iss 2, p e31177 (2012)
PLoS ONE
PLoS ONE
Background Influenza virus remains a significant health and social concern in part because of newly emerging strains, such as avian H5N1 virus. We have developed a prototype H5N1 vaccine using a recombinant, replication-competent Adenovirus serotype
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d64155d5be69e02a6b83f7edae587186
http://europepmc.org/articles/PMC3281928?pdf=render
http://europepmc.org/articles/PMC3281928?pdf=render
Autor:
Duane E. Johnson, Isabella A. Atencio, Ken N. Wills, Barry J. Sugarman, Loretta L. Nielsen, Gerry Hajian, Jennifer Philopena, Suganto Sutjipto, Mei-Ting Vaillancourt, Margarita Nodelman, Diane McAllister, Saskia Neuteboom, Murali Ramachandra, Jenny B. Avanzini, Josefina C. Beltran
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy. 4(1)
TP53 is the most commonly altered tumor-suppressor gene in cancer and is currently being tested in Phase II/III gene replacement trials. Many tumors contain wild-type TP53 sequence with elevated MDM2 protein levels, targeting p53 for degradation. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9bcd98d8cedfe66f8b2ba95bb34a210
https://pubmed.ncbi.nlm.nih.gov/11472100
https://pubmed.ncbi.nlm.nih.gov/11472100